Alnylam to webcast conference call discussing full results from illuminate-a phase 3 study of lumasiran at era-edta international congress

Alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that management will discuss full results from th

ALNY Ratings Summary

ALNY Quant Ranking